Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series

Three patients diagnosed with severe COVID‐19 pneumonia received treatment with hydroxychloroquine combined with lopinavir, ritonavir, and favipiravir. Two patients diagnosed early, received tocilizumab when the pneumonia became severe and survived. The thrid patient was diagnosed late and received...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Case Rep
Päätekijät: Surabotsophon, Manoon, Klai‐On, Yingyot, Thanachartwet, Vipa, Khunapornphairote, Sirote, Chamnanchanunt, Supat, Racharak, Theerapat, Laisuan, Wannada, Sahassananda, Duangjai, Hapunna, Samlee, Jinapuk, Somjit, Leelasetakul, Suthee, Desakorn, Varunee
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Case Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675634/
https://ncbi.nlm.nih.gov/pubmed/33230415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3407
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia